HMCN1 and Axenfeld-Rieger syndrome: The results showed that the myocardial infarction size in ARS + miR-29b-3p inhibitor + si-HMCN1 group was significantly smaller than that in the ARS + miR-29b-3p inhibitor group (Figure 6B).